Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris
- PMID: 3154312
- DOI: 10.1007/BF02125837
Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris
Abstract
The comparative effects of prolonged chronic therapy with diltiazem, nicardipine, tiapamil and verapamil on exercise tolerance, ST-segment changes and heart rate were examined in 63 patients with established chronic stable angina pectoris. Multistage computer-assisted symptom-limited treadmill exercise tests were performed after 2 weeks of placebo ("baseline") and then after 4 months of open-label chronic drug therapy. Diltiazem improved the exercise duration by 95% (p less than 0.001), nicardipine by 45% (p less than 0.001), tiapamil by 69% and verapamil by 79% (p less than 0.001). Maximal ST-segment depression was not altered by any of the drugs, but time to the development of 1 mm ST-segment depression was significantly improved in all cases. Diltiazem and verapamil reduced the heart rate at rest significantly by 6 and 8 beats/minute, respectively, whereas nicardipine increased it by 10 beats/minute (p less than 0.02), and tiapamil did not produce any significant change. Maximal heart rate at the peak of exercise was increased by 14% with nicardipine (p less than 0.001) and 6% with verapamil (p less than 0.05), whereas diltiazem and tiapamil did not produce any appreciable effect. The rate-pressure product at the peak of exercise remained unaltered with diltiazem, tiapamil and verapamil, but with nicardipine it increased significantly to 222 +/- 10 units from a baseline of 175 +/- 6 units with placebo.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Tiapamil, a new calcium channel blocking agent for the treatment of effort induced chronic stable angina pectoris.Eur J Clin Pharmacol. 1986;30(4):387-92. doi: 10.1007/BF00607949. Eur J Clin Pharmacol. 1986. PMID: 3743614 Clinical Trial.
-
Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris.Eur J Clin Pharmacol. 1989;37(4):325-31. doi: 10.1007/BF00558494. Eur J Clin Pharmacol. 1989. PMID: 2513206 Clinical Trial.
-
A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris.Eur J Clin Pharmacol. 1987;32(6):539-48. doi: 10.1007/BF02455985. Eur J Clin Pharmacol. 1987. PMID: 3653222
-
[Treatment of angina pectoris with calcium antagonists].Herz. 1982 Aug;7(4):221-34. Herz. 1982. PMID: 6751971 Review. German. No abstract available.
-
Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.Am J Cardiol. 1985 Jan 25;55(3):69B-80B. doi: 10.1016/0002-9149(85)90615-0. Am J Cardiol. 1985. PMID: 2857518 Review.
Cited by
-
Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.Cardiovasc Drugs Ther. 1988 Jan;1(5):461-91. doi: 10.1007/BF02125731. Cardiovasc Drugs Ther. 1988. PMID: 3154677 Review.
-
Calcium channel antagonists. Part V: Second-generation agents.Cardiovasc Drugs Ther. 1988 Jul;2(2):191-203. doi: 10.1007/BF00051234. Cardiovasc Drugs Ther. 1988. PMID: 3154705 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical